Karyopharm Therapeutics Inc NASDAQ NMS - GLOBAL MARKET:KPTI
Institutional holders, quarter-over-quarter share deltas, and new and closed positions disclosed in Form 13F. Period 2025-09-30 · prior 2025-06-30.
New Positions(1)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| NEW YORK STATE COMMON RETIREMENT FUND | 148,248 | +148,248 | $350.9K | +$350.9K | — |
Reduced(1)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| Birchview Capital, LP | 27,985 | 0 | $183.0K | +$62.4K | 0.0% |
Sold Out(3)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| DEUTSCHE BANK AG\ | 0 | -1,268,777 | $0 | -$862.8K | — |
| Brinker Capital Investments, LLC | 0 | -24,004 | $0 | -$27.6K | — |
| ADVISOR GROUP HOLDINGS, INC. | 0 | -4,879 | $0 | -$3.3K | — |
Top Holders by reported value
Ranked by the dollar value reported on the latest Form 13F. Share counts reflect long positions as of 2025-09-30.
| Manager | Shares | $ Value | Δ Shares | QoQ % |
|---|---|---|---|---|
| NEW YORK STATE COMMON RETIREMENT FUND | 148,248 | $350.9K | +148,248 | — |
| Birchview Capital, LP | 27,985 | $183.0K | 0 | 0.0% |
New & Closed Positions this quarter
Methodology
Form 13F is the SEC's quarterly disclosure for institutional investment managers exercising discretion over $100 million or more in qualifying U.S. equity securities. Managers must file within 45 days of each calendar quarter end, which is why holdings shown here reflect a snapshot at the period date — not real-time positioning.
Quarter-over-quarter deltas compare each manager's most recently reported share count for KPTI against its prior-quarter count. New positions are entries where the prior count was zero; closed positions are entries where the current count is zero. Amendments (13F-HR/A) replace prior filings for the same period.
Source: SEC EDGAR Form 13F (XML information tables). Dollar values are as reported by the manager and may use mid-quarter pricing conventions. CUSIP-to-ticker resolution is best-effort.